Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis
- PMID: 26348268
- DOI: 10.1002/cncr.29640
Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis
Abstract
Background: Stereotactic body radiation therapy (SBRT) has demonstrated high rates of local control with low morbidity and has now emerged as the standard of care for medically inoperable, early stage non-small cell lung cancer (NSCLC). However, the impact of lung SBRT on survival in the elderly population is less clear given competing comorbid conditions. An analysis of the National Cancer Data Base (NCDB) was undertaken to determine whether definitive SBRT improves survival relative to observation alone patients ages 70 years and older.
Methods: The NCDB, a retrospective national database that captures approximately 70% of all patients treated for cancer, was queried for patients aged 70 years or older with early stage (T1-T3N0M0) NSCLC from 2003 to 2006. Overall survival was compared between patients who received stereotactic body radiotherapy alone and those who received no treatment. An extended Cox proportional hazards model was applied to estimate the treatment effect of SBRT.
Results: In total, 3147 patients met the selection criteria for this analysis. SBRT was delivered to 258 patients (8.2%), and 2889 patients (91.8%) received no treatment. There was no significant difference in the distribution of Charlson/Deyo comorbidity index scores between the 2 groups (P = .076). Multivariable analysis revealed improved overall survival with SBRT compared with observation for the entire cohort (hazard ratio, 0.64; P < .001).
Conclusions: SBRT is associated with improved survival in elderly patients with early stage NSCLC who have concurrent comorbid conditions compared with observation alone. The current data support the use of SBRT for the treatment of elderly patients with early stage NSCLC who have limiting comorbid conditions.
Keywords: elderly; non-small cell lung cancer; observation; radiosurgery; stereotactic body radiation therapy.
© 2015 American Cancer Society.
Similar articles
-
Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.Acta Oncol. 2013 Oct;52(7):1552-8. doi: 10.3109/0284186X.2013.813635. Epub 2013 Aug 1. Acta Oncol. 2013. PMID: 23902274 Clinical Trial.
-
Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy.Radiat Oncol. 2015 May 28;10:120. doi: 10.1186/s13014-015-0423-7. Radiat Oncol. 2015. PMID: 26018408 Free PMC article.
-
Lung stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer in the very elderly (≥80years old): Extremely safe and effective.J Geriatr Oncol. 2017 Sep;8(5):351-355. doi: 10.1016/j.jgo.2017.07.002. Epub 2017 Jul 21. J Geriatr Oncol. 2017. PMID: 28739159
-
Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly.Semin Oncol. 2018 Aug;45(4):210-219. doi: 10.1053/j.seminoncol.2018.06.002. Epub 2018 Jul 1. Semin Oncol. 2018. PMID: 30286944 Review.
-
Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes.Discov Med. 2010 May;9(48):411-7. Discov Med. 2010. PMID: 20515609 Review.
Cited by
-
Safety and clinical outcomes of computed tomography-guided percutaneous microwave ablation in patients aged 80 years and older with early-stage non-small cell lung cancer: A multicenter retrospective study.Thorac Cancer. 2019 Dec;10(12):2236-2242. doi: 10.1111/1759-7714.13209. Epub 2019 Nov 3. Thorac Cancer. 2019. PMID: 31679181 Free PMC article.
-
Stereotactic Body Radiation Therapy for Biopsy-Proven Primary Non-Small-Cell Lung Cancer: Experience of Patients With Inoperable Cancer at a Single Brazilian Institution.J Glob Oncol. 2018 Jul;4:1-8. doi: 10.1200/JGO.18.00020. J Glob Oncol. 2018. PMID: 30085881 Free PMC article.
-
Is severe emphysema, as defined by quantitative CT measurement, a negative risk factor of radiation fibrosis?Br J Radiol. 2018 Jul;91(1087):20170921. doi: 10.1259/bjr.20170921. Epub 2018 Apr 20. Br J Radiol. 2018. PMID: 29651875 Free PMC article.
-
Stereotactic Body Radiotherapy for Early-stage Non-small-cell Lung Cancer in Patients 80 Years and Older: A Multi-center Analysis.Clin Lung Cancer. 2017 Sep;18(5):551-558.e6. doi: 10.1016/j.cllc.2017.03.006. Epub 2017 Mar 16. Clin Lung Cancer. 2017. PMID: 28373068 Free PMC article.
-
Evaluation of the relationship between the range of radiation-induced lung injury on CT images after IMRT for stage I lung cancer and dosimetric parameters.Ann Med. 2021 Dec;53(1):267-273. doi: 10.1080/07853890.2020.1869297. Ann Med. 2021. PMID: 33430616 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous